Admescope is a preclinical contract research organisation (CRO) providing tailor-made ADME-Tox (Absorption, Distribution, Metabolism, Excretion and Toxicity) services for drug discovery and development companies. Our unique expertise lies in drug metabolism, drug interactions, pharmacokinetics and quantitative bioanalysis, where we stand out with our innovative approach combined with the latest technology.
We are very committed to working closely with our customers through the whole study process. All of the studies include comprehensive study planning, tailoring the assay according to the compound(s) and interpretation of the results with recommendations for the future. Our careful individualistic approach enables us to provide high scientific and technical data quality that our customers’ can truly rely on in their decision making.